What is the recommended treatment regimen for iron deficiency anemia using iron sucrose (intravenous iron) 500mg injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Iron Sucrose 500mg Injection Treatment Regimen for Iron Deficiency Anemia

Intravenous iron sucrose 500mg should be administered as two separate 250mg infusions, each diluted in a maximum of 250mL of 0.9% NaCl, given over 15-30 minutes, with the doses separated by at least one week. 1, 2, 3

Indications for IV Iron Sucrose

IV iron sucrose is indicated when:

  • Patient does not tolerate oral iron
  • Ferritin levels do not improve with oral iron trial
  • Patient has a condition where oral iron absorption is compromised 1
  • Hemoglobin is below 10 g/dL requiring rapid correction 2
  • Patient has inflammatory bowel disease with active inflammation 1
  • Patient has undergone bariatric procedures 1
  • Patient has ongoing bleeding who doesn't respond to oral iron therapy 1

Administration Protocol

Dosing:

  • Standard single dose: 200-300mg per infusion 2, 3
  • For 500mg total dose: Split into two 250mg infusions
  • Each mL of iron sucrose contains 20mg of elemental iron 3

Administration Method:

  1. Dilution: Dilute 250mg in maximum 100-250mL of 0.9% NaCl 3
  2. Infusion Rate: Administer over 15-30 minutes 2, 3
  3. Frequency: Space doses at least one week apart
  4. No test dose required: Unlike older iron formulations, no test dose is needed 1, 3

Monitoring and Response Assessment

  • Check hemoglobin 2-4 weeks after treatment 2
  • Target increase: At least 2 g/dL within 4 weeks 2
  • Check iron parameters (ferritin, transferrin saturation) 8-10 weeks after infusion 2
  • Target parameters:
    • Hemoglobin: 10-12 g/dL
    • Ferritin: >100 ng/mL
    • Transferrin saturation: >20% 2

Safety Considerations

  • True anaphylaxis is very rare (less than 1:200,000 administrations) 1, 2
  • Most reactions are complement activation-related pseudo-allergy (infusion reactions) 1
  • Have resuscitation facilities available during administration 2
  • Monitor vital signs during and after infusion
  • No special precautions needed for patients with previous iron dextran sensitivity 4

Clinical Efficacy

Iron sucrose has demonstrated significant efficacy in:

  • Rapidly increasing hemoglobin levels (average increase of 3.29 g/dL for women and 4.58 g/dL for men) 5
  • Improving ferritin and transferrin saturation levels 6, 4
  • Achieving response rates (hemoglobin increase ≥2 g/dL) in 84-94% of patients 5

Common Pitfalls and Caveats

  • Avoid underdilution: Always dilute to recommended concentration to minimize adverse effects
  • Don't exceed recommended infusion rate: Faster administration increases risk of reactions
  • Don't miss follow-up monitoring: Failure to check response may lead to under-treatment
  • Consider underlying conditions: Treat active inflammation in IBD to enhance iron absorption 1
  • Avoid substituting with iron sucrose similars: These may have different efficacy and safety profiles 6

Iron sucrose is a well-established, effective, and generally well-tolerated treatment for iron deficiency anemia with over 70 years of clinical experience 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Iron Deficiency Anemia Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.